Catalist

Directions Website Contact the business

Catalist The stock exchange for New Zealand’s growth economy. https://linktr.ee/catalist

Following recognition with the 2026 Landlord Innovation Award and a 26.7% increase in NAV per share over the past year, ...
07/10/2026

Following recognition with the 2026 Landlord Innovation Award and a 26.7% increase in NAV per share over the past year, Prime Campus is currently holding its latest secondary trading event on Catalist.

This provides existing and prospective retail investors with an opportunity to buy and sell shares in the Fund through Catalist.

⏰ The trading event is currently open and will pre-close on 12 October 2026 at 12:00am.

Learn more about Prime Campus and the current trading opportunity here: https://www.catalist.co.nz/businesses/93a44c94-3570-4278-9bb3-f774678a2e04

When people hear the term "licensed market", it's easy to assume it's just regulatory jargon.But for investors, it makes...
06/10/2026

When people hear the term "licensed market", it's easy to assume it's just regulatory jargon.

But for investors, it makes a real difference.

Being a licensed market operator under the FMCA comes with significant obligations.

As one of only two licensed markets in New Zealand, Catalist operates within a regulatory framework designed to support fair, orderly and transparent markets.

We've broken it down into a simple explainer.

Swipe through to learn more 👉

💡 Raising capital is about more than having a great growth story.Investors want to see a business that's prepared, trans...
29/09/2026

💡 Raising capital is about more than having a great growth story.

Investors want to see a business that's prepared, transparent, and ready for scrutiny.

Before launching your next capital raise, ask yourself these questions covering strategy, governance, financial transparency and more.

How many can you confidently tick off? ✅

🏍️ Founded in 2020, FTN Motion designs, engineers and builds electric motorcycles in New Zealand. Now in 2026, momentum ...
23/09/2026

🏍️ Founded in 2020, FTN Motion designs, engineers and builds electric motorcycles in New Zealand. Now in 2026, momentum has never been stronger.

⚡ The recent launch of the Streetdog XR has driven the company's strongest sales period on record. FTN has exceeded its total FY26 sales volume within the first four months of FY27, is tracking toward more than 50% market share in the New Zealand electric motorcycle market and is maintaining a premium pricing position above its major competitors. Australian sales are live and growing through an expanding network of agent and dealer partners across the continent.

🦘 Looking ahead, FTN is scaling its NZ/AU commercial engine, improving gross margins through a structured cost-reduction programme, and laying the foundations for entering its first northern hemisphere market ahead of a planned Series A raise in 2027.

To support these growth initiatives, FTN Motion is raising NZ$2.0 million through a Convertible Loan Agreement (CLA).

Learn more about FTN Motion and the investment opportunity here: https://www.catalist.co.nz/businesses/8f1311a8-f463-443e-96e4-a1b1c7872591

📰 The Financial Markets Authority NZ has released its latest review of how well we are meeting our licensed market opera...
22/09/2026

📰 The Financial Markets Authority NZ has released its latest review of how well we are meeting our licensed market operator obligations.

⚖️ The review recognised Catalist's strong approach to governance, oversight and controls, highlighting the effectiveness of the framework that supports the markets we operate.

⭐ We're committed to maintaining high regulatory standards and providing issuers, investors and market participants with confidence in a fair, orderly and transparent market.

Read the review here: https://www.fma.govt.nz/library/reports-and-papers/catalist-market-operator-obligations-review/

🧬 STIR Pharma is developing STIR-101, a potential treatment for Long Covid and related post-viral syndromes, with the go...
16/09/2026

🧬 STIR Pharma is developing STIR-101, a potential treatment for Long Covid and related post-viral syndromes, with the goal of addressing a growing global health challenge affecting millions of people worldwide.

🔬 By repurposing a drug candidate backed by decades of research, which has completed early-stage clinical studies, the company is accelerating its path to market. A Phase 2 clinical trial is currently underway, with plans to pursue a US FDA filing following successful completion.

💡 With a highly experienced team, secured intellectual property rights and a clear commercialisation strategy, STIR Pharma is positioning itself at the forefront of innovation in post-viral health.

Learn more about STIR Pharma on their marketplace page: https://lnkd.in/eyJ9hvcp

Many businesses on Catalist use our nominee service to simplify investor administration and maintain a cleaner cap table...
15/09/2026

Many businesses on Catalist use our nominee service to simplify investor administration and maintain a cleaner cap table.

But what does that mean for investors?

We've broken down how nominee structures work and answered some common investor queries.

Swipe to learn more 👉

📈 Following strong portfolio growth and continued expansion, Prime Campus secondary trading is now open until 22 July.🏘️...
15/07/2026

📈 Following strong portfolio growth and continued expansion, Prime Campus secondary trading is now open until 22 July.

🏘️ Prime Campus provides investors with exposure to a diversified portfolio of student accommodation assets located near New Zealand university campuses.

The company recently reported:
- Portfolio value growth to $20.4 million, up 24.4% quarter-on-quarter
- NAV per share of $0.85, up 27.2% year-on-year
- 2 Christchurch acquisitions supporting future development and portfolio expansion

This opportunity is open to all investors.

Learn more about Prime Campus on their marketplace page: https://www.catalist.co.nz/businesses/93a44c94-3570-4278-9bb3-f774678a2e04

Catalist welcomes the Government's capital markets reforms phase 2 discussion document (accessible here: https://www.mbi...
14/07/2026

Catalist welcomes the Government's capital markets reforms phase 2 discussion document (accessible here: https://www.mbie.govt.nz/dmsdocument/32285-capital-markets-reforms-phase-two-discussion-document) and its focus on improving access to capital and liquidity for growing New Zealand businesses.

The consultation recognises the need for a stronger equity ladder, with proportionate pathways between private capital raising, crowdfunding, Catalist and NZX.

We particularly support proposals to remove the current market capitalisation thresholds that limit which companies can access the Catalist Public Market. Rather than relying on size alone, regulation should focus on the nature of the activity - how much capital is being raised, from whom, what information is provided, and the investor protections in place.

Under this approach, NZX would remain the natural market for larger companies seeking continuous trading, deeper institutional capital and larger public raises, while Catalist would continue to serve as a stepping-stone market for companies not yet ready for a traditional public listing.

We also support reforming audit requirements so they are based on the scale and nature of capital raising activity, and the number of retail investors affected, rather than simply whether a company is classified as "listed" or "unlisted". This is particularly important for businesses with existing retail shareholders (including many that have raised capital through crowdfunding) that currently face barriers to providing liquidity.

Overall, this is a positive step toward a more proportionate capital markets framework that makes it easier for New Zealand growth businesses to access capital and provide liquidity, while maintaining strong investor protection through transparent, regulated markets.

Have your say on the consultation here: mbie.govt.nz/have-your-say/consultation-on-capital-markets-reform

🧑‍🌾GrowPay is digitising agriculture with a financial platform built specifically for NZ farmers - unlocking better deal...
18/06/2026

🧑‍🌾GrowPay is digitising agriculture with a financial platform built specifically for NZ farmers - unlocking better deals, smarter financing, and stronger margins.

⚡GrowPay’s all-in-one app combines payments, lending, and a marketplace into a single digital wallet - giving farmers instant access to funding, seamless bill payments, and wholesale-priced inputs. By partnering with banks and aggregating demand, the platform is delivering more competitive rates and reducing on-farm costs by an initial target of 5–10%.

📱Existing integrations include Apple Pay, Mastercard, and Aon‑Agri, bringing payments and financing into one ecosystem.

The company is currently raising capital to drive growth beyond initial successful pilots.

Wholesale Investors can learn more about GrowPay and invest here: https://www.catalist.co.nz/businesses/7b1d0efb-decc-45ea-a494-7521e171a1cc

Address

Level 2/187 Queen Street
Auckland
1010

Alerts

Be the first to know and let us send you an email when Catalist posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Catalist:

Shortcuts

Sponsored

Share